Medical Device News

What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and enthusiasts. This digital publication acts as a crucial source of information, providing valuable perspectives on state-of-the-art innovations, regulatory changes, FDA updates on medical devices, and industry trends affecting patient care and business approaches. Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking news and articles authored by experts in this space. This content aims to stimulate discussions on advancements in medical devices and biotechnology, and their impact on the future of medicine.

Smart Reactors: Revolutionizing Medical Device Coatings with Innovative Biocompatibility Solutions

Smart Reactors, an innovative medical technology company with headquarters in Ireland, is addressing this challenge head-on with its groundbreaking Camouflage™ coating technology.

Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices

Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact."

BiVACOR Total Artificial Heart Successfully Implanted in First Patient in Australia; TAH in Place Over 100 Days

Following weeks of in-hospital monitoring, the patient was the first in the world to be discharged from the hospital with the BiVACOR Total Artificial Heart as he awaited a heart transplant. After having the device for 105 days, a donor heart became available, and the patient received a heart transplant on March 6, 2025.

Industry Expert Byline

Preparing for the Logistical Complexities Presented by Personalized Medicine | By Tim McClatchy, VP Life Sciences at Kenco

With the right mix of planning, monitoring and data management, carriers can successfully deliver the tools and treatments that make the personalized medicine revolution possible.

Biotechnology News

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Guido Baechler, CEO of Mainz Biomed: “Securing the exclusive rights to license this portfolio of novel biomarkers is a major milestone and extension of our previously announced PancAlert program. It provides us with an extraordinary opportunity in the early detection and diagnosis of one of the most challenging cancers to treat. We believe that this achievement marks a paradigm shift in how we can detect pancreatic cancer."

Medigene Submits Patent for Unique NK-Specific TCR Construct with European Patent Office

"This innovative approach supports our strategy to apply Medigene’s 3S TCRs into new TCR-guided modalities, such as TCR-TCEs and now TCR-NKs, to create additional value for both patients and our shareholders,” said Selwyn Ho, CEO of Medigene. “Expanding our TCR-guided therapies to include NK cells aligns with our commitment to developing off-the-shelf, highly specific, and effective immunotherapies for cancer treatment."

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

Dave Mehalick, CEO of COEPTIS stated, “Partnering with NUBURU marks a significant step in COEPTIS' journey toward pioneering innovative technology solutions. By harnessing the power of NexGen’s AI-driven capabilities, we are poised to not only enhance our own operational efficiencies but also redefine how businesses engage with their clients in the rapidly evolving defense and security landscape. This collaboration underscores our commitment to fostering growth through advanced technological integrations.”

NeuralCure AI Announces Partnership with Life Imaging FLA

This partnership immediately positions NeuralCure AI for rapid, real-world application, further solidifying its role as a pioneer in AI-powered healthcare solutions. Unlike traditional AI models that provide generalized insights, NeuralCure AI creates patient-specific digital twins and runs constant treatment simulations, helping physicians make more informed, data-driven decisions without replacing clinical judgment.

Clinical Trials and Updates

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025

Vidofludimus Calcium's Activation of Nurr1 reduces neuronal loss and injury directly and Indirectly by decreasing microglial activations in preclinical models.

Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial

The Audiogene trial is designed to evaluate the safety, tolerability and efficacy of intra-cochlear injection of SENS-501 for the treatment of OTOF gene-mediated hearing loss in paediatric patients aged between 6 and 31 months at the time of gene therapy treatment. By targeting the first years of life, when brain plasticity is at its peak, the chances of these young children with pre-linguistic hearing loss of acquiring normal speech and language are maximised. The trial is comprised of two cohorts of two doses followed by an expansion cohort at the selected dose.

Expert Bylines

Preparing for the Logistical Complexities Presented by Personalized Medicine | By Tim McClatchy, VP Life Sciences at Kenco

With the right mix of planning, monitoring and data management, carriers can successfully deliver the tools and treatments that make the personalized medicine revolution possible.

Fixing a $5 Trillion Problem by Rewriting the Rules of Healthcare | By Mark Newman, CEO of Nomi Health

The real question isn’t whether healthcare can be fixed—it’s whether we’re ready to accelerate the change or stay stuck in a broken, outdated model.

Who We Are

3 Key Insights About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Market Reports

Latent TB Testing Market Research 2025

The "Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.

Cell Counting Market to Hit USD 16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. Advancements in technology, increased research initiatives, and the rising demand for precision diagnostics are key factors driving the global cell counting market.

FDA Updates

Phantom Neuro Receives FDA Breakthrough Device & TAP Designations, Solidifying Position as a Neurotech Leader

"Receiving both of these certified designations from the FDA is a tremendous validation of our work," said Dr. Connor Glass, Founder and CEO of Phantom Neuro. "These recognitions validate our technology and reflect our commitment to creating scalable, real-world solutions that restore functionality and independence to amputees and those with functional disabilities. Our goal is to bring Phantom X to patients faster, and achievements like this accelerate our clinical and regulatory processes."

FDA Approves LANCELOT Technology for Corcym’s Perceval Plus, Enhancing Performance of Sutureless Aortic Valve Replacement

Lancelot Technology: CORCYM , the medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces...

Acquisitions /Mergers

Boston Scientific Reveals Agreement to Acquire SoniVie Ltd.

"Renal denervation for hypertension is an exciting medical advancement for the millions of patients it may help and is supported by positive results from contemporary clinical trials and ongoing research," said Lance Bates, senior vice president and president, Interventional Cardiology Therapies, Boston Scientific. "We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension and provides opportunity for future advancements in this space."

Funding

Exciting Times Ahead for TRIMTECH Therapeutics with $31M Seed Funding

The investment will support further development of TRIMTECH Therapeutics growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.

Executives on the Move

Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics

"I am honored to lead Nimbus at this pivotal time in the company's evolution," said Abbas Kazimi. "Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I'm particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”

Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec

Mirva Ekman over 20 years of experience in quality and regulatory leadership.

Kristen Cardillo Takes Charge as Senior VP Chief Communications Officer at Zimmer Biomet

Kristen Cardillo will join the Company on March 10, 2025, to lead Zimmer Biomet's global communications strategy, enhancing engagement with key stakeholders and amplifying the Company's position as a leader in MedTech.

Hospitals in the News

Covenant Health Fort Sanders Regional 1st in Tennessee to Bring Perimeter Medical Imaging AI’s Pioneering Technology to Surgery

"OCT technology enhances the level of care I am able to provide and has become a valuable tool in the operating room," said Dr. Ana Wilson, a surgical oncologist with Covenant Health Fort Sanders Regional. "It allows me to make patient-specific surgical decisions in real-time and potentially reduce the likelihood of my patients returning for a second surgery."

Non Profit Happenings

Header Restriction Policy in Youth Soccer Shows Promising Impact on Concussion Rates

Researchers found that the policy was associated with a decrease in soccer-related concussions; however, female players experienced a higher proportion of concussions than their male counterparts.
The Business of Healthcare

Business

Telemedicine: Bridging the Gap in Healthcare Access and Delivery

The healthcare industry has seen significant changes and transformations in the rapidly advancing world of technology. One of the most groundbreaking developments in recent...

Healthcare Professionals

A Comprehensive Tax Planning Guide For Medical Professionals

In this article, doctors can use these strategies to maximize their deductions and receive the most retirement benefits possible.

Careers

The Growing Surge in Health Science Careers and How to Navigate Your Path

Introduction As modern societies strive for better health outcomes, the role of health science professionals becomes increasingly vital. These experts are the backbone of efforts...

Nurses Corner

Conexus MedStaff And Angat Buhay Introduce Partnership to Improve Community Health In Naga City, Philippines

The grant from Conexus MedStaff will aid the recovery and rehabilitation of community healthcare services in Naga City, which were severely affected by the devastation of Tropical Storm Kristine in October 2024.

Health / Lifestyle

Articles of Interest

Explore our medtech publication to delve into the convergence of technology and healthcare, enabling well-informed choices and promoting collaboration in this ever-evolving field. For advertising inquiries, please reach out to us. The publication is a division of PTM Healthcare Marketing, Inc. Inquire about advertising.